购物车
您的购物车当前为空
MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name.

MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 19,400 | 10-14周 | |
| 50 mg | ¥ 25,800 | 10-14周 | |
| 100 mg | ¥ 33,500 | 10-14周 |
| 产品描述 | MDK6465, also known as PCSK9-IN-8b, is a novel liver-targeted inhibitor of ribosomal synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). MDK6465 has CAS#1900686-46-5. the last 4 digits are used in its name. |
| 分子量 | 598.03 |
| 分子式 | C27H29ClFN9O4 |
| CAS No. | 1900686-46-5 |
| Smiles | CN1C(=C(C=N1)C2=C(F)C=C(C(N(C3=C(Cl)C=CC=N3)[C@@H]4CCCNC4)=O)C=C2)C=5N([C@@H](OC(OCC)=O)C)N=NN5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多